Literature DB >> 4461778

Application of the Wagner-Nelson absorption method to the two-compartment open model.

J G Wagner.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4461778     DOI: 10.1007/BF01070942

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


× No keyword cloud information.
  7 in total

1.  SOME POSSIBLE ERRORS IN THE PLOTTING AND INTERPRETATION OF SEMILOGARITHMIC PLOTS OF BLOOD LEVEL AND URINARY EXCRETION DATA.

Authors:  J G WAGNER
Journal:  J Pharm Sci       Date:  1963-11       Impact factor: 3.534

2.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1964-11       Impact factor: 3.534

3.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

4.  Calculation of absorption rate constants for drugs with incomplete availability.

Authors:  D Perrier; M Gibaldi
Journal:  J Pharm Sci       Date:  1973-02       Impact factor: 3.534

5.  Calculating absorption rate constants for drugs with incomplete availability.

Authors:  L J Leeson; H Weintraub
Journal:  J Pharm Sci       Date:  1973-12       Impact factor: 3.534

6.  Effect of parallel first-order loss from site of administration on calculated values for absorption rate constants.

Authors:  R E Notari; J L DeYoung; R H Reuning
Journal:  J Pharm Sci       Date:  1972-01       Impact factor: 3.534

7.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

  7 in total
  14 in total

1.  Do you need a pharmacokinetic model, and, if so, which one?

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  SPLINDID: a semi-parametric, model-based method for obtaining transcription rates and gene regulation parameters from genomic and proteomic expression profiles.

Authors:  Kavitha Bhasi; Alan Forrest; Murali Ramanathan
Journal:  Bioinformatics       Date:  2005-08-11       Impact factor: 6.937

3.  Application of SPLINDID, a semiparametric, model-based method for pharmacogenomic modeling of mRNA dynamics.

Authors:  Kavitha Bhasi; Alan Forrest; Murali Ramanathan
Journal:  Pharm Res       Date:  2006-03-24       Impact factor: 4.200

4.  Investigation of absorption kinetics by the phase plane method.

Authors:  A Dokoumetzidis; P Macheras
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

5.  A pharmacokinetic-pharmacodynamic study of a single dose of febuxostat in healthy subjects.

Authors:  Bishoy Kamel; Garry G Graham; Sophie L Stocker; Zhixin Liu; Kenneth M Williams; Jane E Carland; Kevin D Pile; Richard O Day
Journal:  Br J Clin Pharmacol       Date:  2020-06-18       Impact factor: 4.335

6.  An incremental method for the study of the absorption of drugs whose kinetics are described by a two-compartment model: estimation of the microscopic rate constants.

Authors:  A Gerardin; D Wantiez; A Jaouen
Journal:  J Pharmacokinet Biopharm       Date:  1983-08

7.  Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects.

Authors:  M Rochdi; A Sabouraud; C Girre; R Venet; J M Scherrmann
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 8.  Pharmacokinetic data processed by microcomputer for the formulation of optimal drug dosage form.

Authors:  J M Aiache; M Turlier; A Tanguy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Apr-Jun       Impact factor: 2.441

9.  Evaluating drug absorption after oral administration. Some problems and some solutions.

Authors:  K K Chan; M Gibaldi
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 10.  Bioavailability of drugs: the digoxin dilemma.

Authors:  D J Greenblatt; T W Smith; J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.